skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)

اصطلاح مرجح

n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-glycoloylneuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -1

فرمول

  • C50H87N3O27R

جرم

  • 1162.232

جرم تک‌ایزوتوپی

  • 1161.55269

اسمایلٓ

  • [C@@]1(O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@@H](OC[C@@H]([C@@H](CCCCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]3O)O)CO)CO)O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO)O)NC(C)=O)(O[C@H]([C@H](NC(=O)CO)[C@H](C1)O)[C@@H]([C@H](O)CO)O)C([O-])=O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • beta-D-GalNAc-(1->4)-[alpha-NeuGc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:0)(1-)
  • ganglioside GM2(NeuGc) (d18:0)
  • GM2(NeuGc)(d18:0)(1-)
  • N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine(1-)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142038

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD